Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TIAMATE

DILTIAZEM MALATE

Standard Dose
EQ 120MG HYDROCHLORIDE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TIAMATE is listed in Drugs@FDA under application 020506 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DILTIAZEM MALATE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 120MG HYDROCHLORIDE Sponsor MERCK Submission history Latest submission status date: 1996-10-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview TIAMATE is listed in Drugs@FDA under application 020506 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DILTIAZEM MALATE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 120MG HYDROCHLORIDE Sponsor MERCK Submission history Latest submission status date: 1996-10-04 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.